List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 87 studies with search of: "Clarithromycin"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Comparative Study of 5 Days of M02-472 Clarithromycin Extended-Release Tablets to 7 Days of Clarithromycin Immediate-Release Tablets for the Treatment of Exacerbation of Chronic Bronchitis
Condition: Acute Bacterial Exacerbation of Chronic Bronchitis (ABECB).
Interventions: Drug: clarithromycin extended-release tablets;   Drug: clarithromycin immediate-release tablets
2 Completed Clarithromycin, Amoxicillin, and Metronidazole Based Regimens to Treat Helicobacter Pylori Infections in Colombia
Condition: Helicobacter Pylori Infection
Interventions: Drug: Clarithromycin, Metronidazole, Amoxicillin (+Omeprazole);   Drug: Clarithromycin, Amoxicillin, Omeprazole
3 Completed Comparative Bioavailability Study of Clarithromycin 250 mg Tablets
Condition: Healthy
Interventions: Procedure: Clarithromycin;   Drug: Clarithromycin
4 Recruiting Biaxin Based Antibiotic Therapy in Previously Untreated, Advanced Stage Indolent Lymphoma
Condition: Lymphoma
Interventions: Drug: BIAXIN (CLARITHROMYCIN);   Drug: Biaxin (clarithromycin)
5 Completed Clarithromycin in Active Crohn's Disease
Condition: Crohn's Disease
Interventions: Drug: Clarithromycin;   Drug: Placebo
6 Completed Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fed State
Condition: Healthy
Interventions: Drug: Clarithromycin;   Drug: Clarithromycin
7 Completed Comparative Bioavailability Study of Clarithromycin 500 mg Tablets in Fasting State
Condition: Healthy
Interventions: Drug: Clarithromycin;   Drug: Clarithromycin
8 Completed Comparative Study of the Safety and Efficacy of Clarithromycin Extended-Release Tablets Versus Amoxicillin-Clavulanate for the Treatment of Acute Bacterial Sinusitis
Condition: Acute Bacterial Sinusitis (ABS)
Interventions: Drug: Clarithromycin;   Drug: Amoxicillin
9 Completed To Demonstrate the Relative Bioavailability of Clarithromycin 250 mg Tablets Under Non-Fasting Conditions
Condition: Healthy
Interventions: Drug: Clarithromycin 250 mg Tablets (Geneva Pharmaceuticals, USA);   Drug: Biaxin (Clarithromycin) 250 mg Tablets (Abbott Laboratories, Inc, USA)
10 Active, not recruiting Use of Clarithromycin and Rifabutin for the Treatment of M. Avium Complex (MAC) Lung Disease
Condition: Mycobacterium Avium Complex Lung Disease
Intervention: Drug: clarithromycin, rifabutin
11 Completed Study Comparing the Safety and Efficacy of Cethromycin to Clarithromycin for the Treatment of Community-Acquired Pneumonia
Condition: Pneumonia
Interventions: Drug: Cethromycin;   Drug: Clarithromycin
12 Completed Clarithromycin 500 mg Extended Release Tablets Under Fasting Conditions
Condition: Healthy
Interventions: Drug: Clarithromycin ER 500 mg tablets;   Drug: BIAXIN® XL 500 mg tablets
13 Completed Clarithromycin 500 mg Extended Release Tablets Under Non-Fasting Conditions.
Condition: Healthy
Interventions: Drug: Clarithromycin ER 500 mg tablets;   Drug: BIAXIN® XL 500 mg tablets
14 Completed Clarithromycin 500 mg Tablets Under Fasting Conditions
Condition: Healthy
Interventions: Drug: clarithromycin;   Drug: BIAXIN®
15 Completed Clarithromycin 500 mg Tablets Under Non-Fasting Conditions
Condition: Healthy
Interventions: Drug: clarithromycin;   Drug: BIAXIN®
16 Completed The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients
Conditions: Mycobacterium Avium-Intracellulare Infection;   HIV Infections
Interventions: Drug: Clarithromycin;   Drug: Rifabutin
17 Completed Bioequivalence Study of Clarithromycin 250mg Tablets Under Fasting Conditions
Condition: Healthy
Intervention: Drug: clarithromycin 250 mg tablets
18 Completed Bioequivalence Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fasting Conditions
Condition: Healthy
Intervention: Drug: clarithromycin 250 mg/5 mL powder for oral suspension
19 Completed Bioequivaelnce Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fed Conditions
Condition: Healthy
Intervention: Drug: Clarithromycin 250mg/5mL
20 Active, not recruiting Clarithromycin for the Treatment of Infections Caused by Nontuberculous Mycobacteria (NTM)
Conditions: Non-Tuberculous Mycobacteria;   Mycobacterium Avium Complex
Intervention: Drug: Clarithromycin

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services